Inhibikase Therapeutics
Price & Volume
Stats
See more52W Range | $1.33-$2.36 |
Market Cap | $224.4M |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $1 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$30.6M |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • 9 days ago
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Bank of America Predicts Up to 240% Jump for These 2 ‘Strong Buy’ Stocks
Yahoo Finance • 5 months ago
Inhibikase Therapeutics sells 68.97M shares and pre-funded warrants at $1.45/share
Yahoo Finance • 5 months ago
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
About
CEO | Mr. Mark T. Iwicki |
Address | 1000 N. West Street, Wilmington, DE, United States, 19801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 35 |
